Diagnosing malignant hyperthermia susceptibility
- 22 February 2007
- journal article
- Published by Wiley in Anaesthesia
- Vol. 49 (5) , 373-375
- https://doi.org/10.1111/j.1365-2044.1994.tb03465.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Genetic mapping of the β1- and γ-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibilityHuman Molecular Genetics, 1993
- Malignant hyperthermia hots up!Human Molecular Genetics, 1993
- GENETIC LINKAGE ANALYSIS OF CHROMOSOME 19 MARKERS IN MALIGNANT HYPERTHERMIABritish Journal of Anaesthesia, 1993
- Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17qGenomics, 1992
- Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscleClinical Genetics, 1992
- Evidence for genetic heterogeneity in malignant hyperthermia susceptibilityGenomics, 1991
- Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.BMJ, 1991
- Localization of the malignant hyperthermia susceptibility locus to human chromosome 19ql2–13.2Nature, 1990
- Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermiaNature, 1990
- METABOLIC ERROR OF MUSCLE METABOLISM AFTER RECOVERY FROM MALIGNANT HYPERTHERMIAThe Lancet, 1970